These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35984673)

  • 41. Challenges in Translational Development of Pharmaceutical Cocrystals.
    Kale DP; Zode SS; Bansal AK
    J Pharm Sci; 2017 Feb; 106(2):457-470. PubMed ID: 27914793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating.
    Serrano DR; Walsh D; O'Connell P; Mugheirbi NA; Worku ZA; Bolas-Fernandez F; Galiana C; Dea-Ayuela MA; Healy AM
    Eur J Pharm Biopharm; 2018 Mar; 124():13-27. PubMed ID: 29196273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combinatorial crystal synthesis: structural landscape of phloroglucinol:1,2-bis(4-pyridyl)ethylene and phloroglucinol:phenazine.
    Dubey R; Desiraju GR
    Angew Chem Int Ed Engl; 2014 Nov; 53(48):13178-82. PubMed ID: 25284214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.
    Gadade DD; Pekamwar SS
    Adv Pharm Bull; 2016 Dec; 6(4):479-494. PubMed ID: 28101455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.
    Almarsson Ö; Peterson ML; Zaworotko M
    Pharm Pat Anal; 2012 Jul; 1(3):313-27. PubMed ID: 24236844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of Drug Crystallization and Molecular Interactions by Additives in Solid Dispersions for Improving Drug Bioavailability.
    Tran PHL; Duan W; Lee BJ; Tran TTD
    Curr Pharm Des; 2019; 25(18):2099-2107. PubMed ID: 31244413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications.
    Guo M; Sun X; Chen J; Cai T
    Acta Pharm Sin B; 2021 Aug; 11(8):2537-2564. PubMed ID: 34522597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cocrystals of tuberculosis antibiotics: Challenges and missed opportunities.
    Salem A; Khanfar E; Nagy S; Széchenyi A
    Int J Pharm; 2022 Jul; 623():121924. PubMed ID: 35738333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-Drug Binary Solids of Nitrofurantoin and Trimethoprim: Crystal Engineering and Pharmaceutical Properties.
    Maity DK; Paul RK; Desiraju GR
    Mol Pharm; 2020 Dec; 17(12):4435-4442. PubMed ID: 32941048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydrogen-bonding synthons in lamotrigine salts: 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazin-2-ium 2-[(2-carboxyphenyl)disulfanyl]benzoate in its monohydrate and anhydrous forms.
    Freire E; Polla G; Baggio R
    Acta Crystallogr C Struct Chem; 2016 Nov; 72(Pt 11):910-916. PubMed ID: 27811434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contributions of secondary alcohol-ketone O-H...O=C and furan-acetate Csp
    Kenfack Tsobnang P; Tsamo Tontsa A; Mbiangué YA; Kemda Nangmo P; Kenfack Tiofack S; Mkounga P; Nkengfack Ephrem A; Tonlé Kenfack I
    Acta Crystallogr C Struct Chem; 2021 Jun; 77(Pt 6):312-320. PubMed ID: 34089255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.
    Biscaia IFB; Gomes SN; Bernardi LS; Oliveira PR
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy.
    Srivastava D; Fatima Z; Kaur CD
    Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular complexes of alprazolam with carboxylic acids, boric acid, boronic acids, and phenols. Evaluation of supramolecular heterosynthons mediated by a triazole ring.
    Varughese S; Azim Y; Desiraju GR
    J Pharm Sci; 2010 Sep; 99(9):3743-53. PubMed ID: 20665840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous engineering of nano-cocrystals for medical and energetic applications.
    Spitzer D; Risse B; Schnell F; Pichot V; Klaumünzer M; Schaefer MR
    Sci Rep; 2014 Oct; 4():6575. PubMed ID: 25300652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Solid-State Versatility of the Molecular Salts/Cocrystals of 2-Chloro-4-nitrobenzoic Acid: A Case Study on Halogen Bonds.
    Oruganti M; Nechipadappu SK; Khade PA; Trivedi DR
    ACS Omega; 2017 Oct; 2(10):7146-7162. PubMed ID: 31457294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isostructural cocrystals of metaxalone with improved dissolution characteristics.
    Gohel SK; Palanisamy V; Sanphui P; Prakash M; Singh GP; Chernyshev V
    RSC Adv; 2021 Sep; 11(49):30689-30700. PubMed ID: 35479860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride.
    Yadav AV; Dabke AP; Shete AS
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1036-45. PubMed ID: 20334542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of cocrystals in pharmaceutical science.
    Shan N; Zaworotko MJ
    Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.